B

Breckenridge Pharmaceutical Inc.

Breckenridge Pharmaceutical Inc. has settled claims that its generic duloxetine contained a cancer-causing impurity, offering refunds or up to $10 per prescription.

ClosedUnited States-wideClaim status: Closed on December 27, 2025Payout: $10 per prescription or full refundNo longer claimable

About this settlement

Allegations of a cancer-causing impurity in generic duloxetine (Cymbalta) sold by Breckenridge Pharmaceutical Inc.

This settlement resolves claims that Breckenridge Pharmaceutical Inc.'s generic duloxetine (Cymbalta) contained a cancer-causing impurity. Eligible individuals who purchased the medication may receive up to $10 per prescription or a full refund of their out-of-pocket costs. A separate Future Refund Program is also available for qualifying recalled purchases made after May 22, 2025.

Who qualifies

  • Individuals in the U.S. who purchased Breckenridge duloxetine for personal or household use.
  • Purchases for the Class Action Settlement were made between Aug. 4, 2020, and May 22, 2025.
  • Purchases for the Future Refund Program were made after May 22, 2025, for qualifying recalled products.

$10 per prescription or full refund

Claim status: Closed on December 27, 2025

See active Settlements

Related settlements

Keurig logo

Keurig

No proof required

Up to $50

13 days left

πŸ”₯ 505 started this claim

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

113 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

763 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon